Methods for evaluating susceptibility to a bone homeostasis...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S006120, C435S091200, C435S183000, C536S023100, C536S024310, C536S024330, C530S350000

Reexamination Certificate

active

07462447

ABSTRACT:
The invention provides mutant SH3-binding protein (SH3BP2) nucleic acids, polypeptides, and agents which selectively bind to the mutant SH3BP2 molecules and which do not bind to the wild type SH3BP2 molecules. Methods for selecting agents which inhibit mutant SH3BP2 expression, as well as diagnostic and therapeutic methods which utilize the mutant SH3BP2 molecules for diagnosing and treating disorders of bone homeostasis, also are provided.

REFERENCES:
patent: WO 03025197 (2003-03-01), None
New England BioLabs, Inc., Jan. 2001 Catalog and Technical Reference, 2000, p. 125.
Baxendale, S. et al., A cosmid contig and high resolution restriction map of the 2 megabase region containing the Huntington's disease gene. Nature Genetics 4: 181-186, 1993.
Bell, S.M. et al., Identification and characterization of the human homologue of SH3BP2, an SH3 binding domain protein within a common region of deletion at 4p16.3 involved in bladder cancer. Genomics 44: 163-170, 1997.
Bianco, P. et al., Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. Bone Miner Res. 15: 120-128, 2000.
Deckert, M. et al., Adaptor function for the Syk kinases-interacting protein 3BP2 in IL-2 gene activation. Immunity 9: 595-605, 1998.
Gibco BRL Products and References Guide, Radon Primers, 1997, 17-19.
Hadano, S. et al., The primary structure and genomic organization of five novel transcripts located close to the Huntington's disease gene on human chromosome 4p16.3. DNA Research 5: 177-186, 1998.
Hirschhorn, K. et al., Deletion of short arms of chromosome 4-5 in a child with defects of midline fusion. Humangenetik 1: 479-482, 1965.
Jones, W.A., Familial multilocular cystic disease of the jaws. Amer. J. of Cancer 17: 946-950, 1933.
Lewis, J.M. et al., Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport. Proc. Natl. Acad. Sci. USA 93: 15174-15179, 1996.
Li, B. et al., Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation. Nat. Genet. 24: 304-308, 2000.
Mangion, J. et al., The gene for cherubism maps to chromosome 4p16.3. Amer. J. of Human Genetics 65: 151-157, 1999.
Pawson, T. et al., SH2 and SH3 domains: from structure to function. Cell 71: 359-362, 1992.
Pribill, I. et al., Exon trapping and sequence-based methods of gene finding in transcript mapping of human 4p16.3. Somatic Cell & Molecular Genetics 23: 413-427, 1997.
Ren, R. et al., Identification of a ten-amino acid proline-rich SH3 binding site. Science 259: 1157-1161, 1993.
Songyang, Z. et al., Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol. Cell. Biol. 14: 2777-2785, 1994.
Sparks, A.B. et al., Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2. Proc. Natl. Acad. Sci USA 93: 1540-1544, 1996.
Tiziani, V. et al., The gene for cherubism maps to chromosome 4p16. Amer. J. of Human Genetics 65: 158-166, 1999.
Ueki, Y. et al., Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism. Nat Genet. Jun. 2001;28(2):125-6.
Weinstein, L.S. et al., Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N. Engl. J. Med. 325: 1688-1695, 1991.
Welch, P.J. et al., A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75: 779-790, 1993.
Zohar, Y. Fibrous dysplasia and cherubism as an hereditary familial disease. Follow-up of four generations. J Craniomaxillofac Surg. Nov. 1989;17(8):340-4.
Zollino, M. et al., Genotype-phenotype correlations and clinical diagnostic criteria in Wolf-Hirschhorn syndrome. Am. J. Med. Genet. 18: 254-261, 2000.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods for evaluating susceptibility to a bone homeostasis... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for evaluating susceptibility to a bone homeostasis..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for evaluating susceptibility to a bone homeostasis... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4030064

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.